An Evaluation of Hepatotoxicity in Breast Cancer Patients Receiving Injection Doxorubicin

BACKGROUND: Hepatic dysfunction in the cancer unit has a significant impact on patient outcomes. The therapeutic application of anthracycline antibiotics are limited by side-effects mainly myelosuppression, chronic cardiotoxicity, and hepatotoxicity. AIM: To assess the risk of Hepatotoxicity in brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Damodar, G, Smitha, T, Gopinath, S, Vijayakumar, S, Rao, YA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952301/
https://www.ncbi.nlm.nih.gov/pubmed/24669335
http://dx.doi.org/10.4103/2141-9248.126619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952301/
https://www.ncbi.nlm.nih.gov/pubmed/24669335
http://dx.doi.org/10.4103/2141-9248.126619

Ejemplares similares